In hepatocellular carcinoma, SIRT4 acts as a tumor suppressor via the inhibition of PPARβ/δ-induced fatty-acid oxidation and the polarization of macrophages to a pro-inflammatory M1 phenotype [285]. Here, PPARD is linked to hepatocellular carcinoma.